New treatment option for Colorectal Cancer
Official title A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)
ClinicalTrials.gov ID: NCT06314022
What this study is testing
- What it's testing
- Colonoscopy is the gold standard for the diagnosis and resection of preneoplastic lesions, allowing the prevention of colon cancer. A colonoscopy is more efficient with proper preparation of the colon, as it allows for a higher rate of adenoma detection and cecal intubation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 74
You may be able to join if
- -people between 50-69 years old from the CRC screening program with FIT (\>100ng/ml).
- Informed consent granted in writing
You likely can't join if
- Refusal to give informed consent.
- Those who do not have a smartphone with a minimum version of the operating system (Android 4.4 or iOS 14, which cover more than 99% of the terminals...
- Symptomatic patients
- people at elevated risk of CRC due to family history or inherited polyposis diseases or inflammatory bowel disease
The study team makes the final eligibility decision.
Where it's taking place
- Valladolid, Valladolid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valladolid, Valladolid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.